Position in RAPP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$110,738,900
+$18,198,068 QoQ
Shares Held
2,657,521
-10.1% QoQ
Ownership
5.54%
of shares outstanding
% of Portfolio
5.62%
of 13F equity value
Holder Rank
#7
of 159 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RAPP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cormorant Asset Management, LP holds $1,889,506,429 across 46 Biotechnology names. RAPP ranks #4 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
640,000 | $214,265,600 | |
| 2 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
17,878,594 | $136,234,886 | |
| 3 | PBLS |
Parabilis Medicines, Inc.
|
4,615,612 | $126,329,300 | |
| 4 | RAPP |
Rapport Therapeutics, Inc.
This page
|
2,657,521 | $110,738,900 | |
| 5 | ERAS |
Erasca, Inc.
|
6,000,000 | $109,920,000 | |
| 6 | EWTX |
Edgewise Therapeutics, Inc.
|
2,510,000 | $101,981,300 | |
| 7 | EYPT |
EyePoint, Inc.
|
7,000,000 | $100,100,000 | |
| 8 | ALMS |
Alumis Inc.
|
3,285,596 | $92,456,671 |
All Filings in RAPP
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $110,738,900 | 2,657,521 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $110,738,900 | 2,657,521 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $92,540,832 | 2,957,521 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $92,540,832 | 2,957,521 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $91,854,987 | 3,027,521 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $91,854,987 | 3,027,521 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $94,817,873 | 3,192,521 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $33,438,271 | 2,940,921 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $29,497,437 | 2,940,921 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $52,171,938 | 2,940,921 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $60,230,062 | 2,940,921 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $68,390,982 | 2,940,283 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||